Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis

We examined the comparative efficacies of first-line abiraterone and enzalutamide in pre- and postdocetaxel settings in castration-resistant prostate cancer (CRPC) through a trial level meta-analysis. A mixed method approach was applied to 19 unique studies containing 17 median overall survival (OS)...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Prostate Cancer
Autori principali: Fang, Mike, Nakazawa, Mary, Antonarakis, Emmanuel S., Li, Chun
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5735648/
https://ncbi.nlm.nih.gov/pubmed/29359049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8560827
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi